Malignant tumor of colon
|
0.310 |
Biomarker
|
disease |
CTD_human |
In human colon cancer cells, forced overexpression of Eomes enhanced cell viability and protected against staurosporine-induced apoptosis.
|
27539959 |
2016 |
Malignant tumor of colon
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
We screened a panel of human primary colon cancers and patient-matched controls (n = 30) and detected Eomes overexpression at the mRNA and protein level.
|
27539959 |
2016 |
Malignant neoplasm of urinary bladder
|
0.310 |
Biomarker
|
disease |
CTD_human |
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
|
26039340 |
2015 |
Bladder Neoplasm
|
0.310 |
Biomarker
|
disease |
CTD_human |
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
|
26039340 |
2015 |
Malignant neoplasm of urinary bladder
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.
|
23056278 |
2012 |
Bladder Neoplasm
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.
|
23056278 |
2012 |
Gastro-enteropancreatic neuroendocrine tumor
|
0.300 |
Biomarker
|
disease |
CTD_human |
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.
|
29915428 |
2018 |
Colonic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.
|
27539959 |
2016 |
Autoimmune Diseases of the Nervous System
|
0.300 |
Biomarker
|
group |
CTD_human |
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
|
27742544 |
2016 |
Immune Disorders, Nervous System
|
0.300 |
Biomarker
|
disease |
CTD_human |
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
|
27742544 |
2016 |
Anxiety Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle.
|
26415720 |
2015 |
Anxiety States, Neurotic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle.
|
26415720 |
2015 |
Anxiety neurosis (finding)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle.
|
26415720 |
2015 |
Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Agenesis of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent infections
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Polymicrogyria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebellar Hypoplasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory distress
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral ventriculomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dilated ventricles (finding)
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Using an adoptive transfer model of cancer immunotherapy, we demonstrate that constitutive eomesodermin (Eomes) expression in tumor-specific CD8 T cells improves tumor rejection and survival.
|
29271784 |
2019 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Moreover, we observed that generation of superior TCM cells in NLGP treated surgically removed tumor hosts is related to the activation of Wnt signalling in memory CD8<sup>+</sup> T cells with concomitant inhibition of GSK-3β and stabilisation of β-catenin, which ultimately activates transcription of Wnt target genes, like, eomesodermin, a signature molecule of CD8<sup>+</sup> TCM cells.
|
28684164 |
2017 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
We conclude from the current investigation, and prior literature, that Eomes has a divergent role in cancer development, with evidence for tumor suppressor and oncogenic functions, depending on stage and tissue context.
|
27539959 |
2016 |